The effect of pulmonary function testing on the success of smoking cessation

Respiratory Care

Volumn 61, Issue 8, 2016, Pages 1073-1080

  Salepci, Banu ^a   Caglayan, Benan ^a   Fidan, Ali ^a   Parmaksiz, Elif Torun ^a   Kiral, Nesrin ^a   Comert, Sevda Sener ^a   Dogan, Coskun ^a   Coskun, Esma ^a  

^a Dr Lutfi Kirdar Kartal Teaching and Research Hospital   (Turkey)

Author keywords

Obstruction; Pulmonary function test; Smoking cessation

Indexed keywords

AMFEBUTAMONE; CARBON MONOXIDE; VARENICLINE;

ADULT; AIRWAY OBSTRUCTION; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; DEPRESSION; FEMALE; FOLLOW UP; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; HYPERTENSION; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; NICOTINE REPLACEMENT THERAPY; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; SCORING SYSTEM; SMOKING CESSATION; SPIROMETRY; ADVERSE EFFECTS; AGE; EVALUATION STUDY; LUNG; MIDDLE AGED; PATHOPHYSIOLOGY; PROCEDURES; SMOKING; STATISTICS AND NUMERICAL DATA; THERAPY; TIME FACTOR; TREATMENT OUTCOME; VITAL CAPACITY;

ADULT; AGE FACTORS; AIRWAY OBSTRUCTION; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HUMANS; LUNG; MALE; MIDDLE AGED; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES; SMOKING; SMOKING CESSATION; SPIROMETRY; TIME FACTORS; TREATMENT OUTCOME; VITAL CAPACITY;

EID: 84982306584     PISSN: 00201324     EISSN: 19433654     Source Type: Journal    
DOI: 10.4187/respcare.04490     Document Type: Article

References (35)

1. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002-2030. PLoS Med 2006;3(11):e442.
2. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Updated 2015. http://www.goldcopd.org/uploads/ users/files/GOLD_Report_2015_Feb18.pdf.
3. Fletcher C, Peto R. The natural history of chronic airflow obstruction. Br Med J 1977;1(6077):1645-1648.
4. Buist AS, Sexton GJ, Nagy JM, Ross BB. The effect of smoking cessation and modifcation on lung function. Am Rev Respir Dis 1976;114(1):115-122.
5. Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years’ observations on male British doctors. Br Med J 2004;328(7455):1519.
6. Anthonisen NR, Skeans MA, Wise RA, Manfreda J, Kanner RE, Connett JE, Lung Health Study Research Group. The effects of a smoking cessation intervention on 14.5-year mortality: a randomised clinical trial. Ann Intern Med 2005;142(4):233-239.
7. Celli BR, MacNee W, ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23(6):932-946.
8. Clinical Practice Guideline Treating Tobacco Use and Dependence 2008 Update Panel, Liaisons, and Staff. A clinical practice guideline for treating tobacco use and dependence: 2008 update. A U.S Public Health Service Report. Am J Prev Med 2008;35(2):158-176.
9. Miranda JAR, Ruiz CAJ, Rebollo JCS. Smoking cessation: update. Clin Pulm Med 2013;20(3):129-136.
10. Zwar NA, Mendelsohn CP, Richmond RL. Supporting smoking cessation: clinical review. Br Med J 2014;348:f7535.
11. Strassmann R, Bausch B, Spaar A, Kleijnen J, Braendli O, Puhan MA. Smoking cessation interventions in COPD: a network meta-analysis of randomised trials. Eur Respir J 2009;34(3):634-640.
12. Jiménez-Ruiz CA, Masa F, Miravitlles M, Gabriel R, Viejo JL, Villasante C, Sobradillo V. Smoking characteristics: differences in attitudes and dependence between healthy smokers and smokers with COPD. Chest 2001;119(5):1365-1370.
13. Kupiainen H, Kinnula VL, Lindqvist A, Postma DS, Boezen HM, Laitinen T, Kilpelainen M. Successful smoking cessation in COPD: association with comorbidities and mortality. Pulm Med 2012;725024. doi: 10.1155/2012/725024.
14. Górecka D, Bednarek M, Nowiński A, Puścińska E, Goljan-Gere-mek A, Zieliński J. Diagnosis of airflow limitation combined with smoking cessation advice increases stop-smoking rate. Chest 2003; 123(6):1916-1923.
15. Bednarek M, Gorecka D, Wielgomas J, Czajkowska-Malinowska M, Regula J, Mieszko-Filipczyk G, et al. Smokers with airway obstruction are more likely to quit smoking. Thorax 2006;61(10):869-873.
16. Clotet J, Gómez-Arbonés X, Ciria C, Albalad JM. Spirometry is a good method for detecting and monitoring chronic obstructive pulmonary disease in high-risk smokers in primary health care. Arch Bronconeumol 2004;40(4):155-159.
17. Stratelis G, Mölstad S, Jakobsson P, Zetterström O. The impact of repeated spirometry and smoking cessation advice on smokers with mild COPD. Scand J Prim Health Care 2006;24(3):133-139.
18. Parkes G, Greenhalgh T, Griffin M, Dent R. Effect on smoking quit rate of telling patients their lung age: the Step2quit randomised controlled trial. Br Med J 2008;336(7644):598-600.
19. Loss RW, Hall WJ, Speers DM. Evaluation of early airway disease in smokers: cost effectiveness of pulmonary function testing. Am J Med Sci 1979;278(1):27-37.
20. Buffels J, Degryse J, Decramer M, Heyrman J. Spirometry and smoking cessation advice in general practice: a randomised clinical trial. Respir Med 2006;100(11):2012-2017.
21. Wilt TJ, Niewoehner D, Kane RL, MacDonald R, Joseph AM. Spirometry as a motivational tool to improve smoking cessation rates: a systematic review of the literature. Nicotine Tob Res 2007;9(1):21-32.
22. Bize R, Burnand B, Mueller Y, Rège-Walther M, Camain JY, Cor-nuz J. Biomedical risk assessment as an aid for smoking cessation (Review). Cochrane Database Syst Rev 2012;(12): CD004705.
23. Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerström Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict. 1991;86(9):1119-1127.
24. Zigmond AS, Snaith RP. “The hospital anxiety and depression scale”. Acta Psychiatr Scand 1983;67(6):361-370.
25. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Series ATS/ERS Task Force: Standardisation of Lung Function Testing. Eur Respir J 2005;26(2): 319-338.
26. Ciprandi G, Capasso M, Tosca M, Salpietro C, Salpietro A, Marseg-lia G, La Rosa M. A forced expiratory flow at 25-75% value 65% of predicted should be considered abnormal: a real-world, cross-sectional study. Allergy Asthma Proc 2012;33(1):e5-e8.
27. Groman E, Bernhard G, Blauensteiner D, Kunze U. A harmful aid to stopping smoking. Lancet 1999;353(9151):466-467.
28. Groman E, Bayer P. A combination of exhaled carbon monoxide (CO) and the Fagerstrom Test for Nicotine Dependence (FTND) is recommended to complete information on smoking rates in popula-tion-based surveys. Soz Praventivmed 2000;45(5):226-228.
29. Petty TL, Pierson DJ, Dick NP, Hudson LD, Walker SH. Follow-up evaluation of a prevalence study for chronic bronchitis and chronic airway obstruction. Am Rev Respir Dis 1976;114(5):881-890.
30. Hepper NG, Drage CW, Davies SF, Rupp WM, LaMothe J, Schoe-nfelder PG, Munson P. Chronic obstructive pulmonary disease: a community oriented program including professional education and screening by a voluntary health agency. Am Rev Respir Dis 1980; 121(1):97-104.
31. Baker TR, Oscherwitz M, Corlin R, Jarboe T, Teisch J, Nichaman MZ. Screening and treatment program for mild chronic obstructive pulmonary disease. JAMA 1970;214(8):1448-1455.
32. Segnan N, Ponti A, Battista RN, Senore C, Rosso S, Shapiro SH, Aimar D. A randomized trial of smoking cessation interventions in general practice in Italy. Cancer Causes Control 1991;2(4):239-246.
33. Humerfelt S, Eide GE, Kvåle G, Aaro LE, Gulsvik A. Effectiveness of postal smoking cessation advice: a randomized controlled trial in young men with reduced FEV1 and asbestos exposure. Eur Respir J 1998;11(2):284-290.
34. Fagerström KO. Assessment of the smoker who wants to quit. Mon-aldi Arch Chest Dis 2001;56(2):124-127.
35. Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, et al. International variation in the prevalence of COPD (The BOLD study): a population based prevalence study. Lancet 2007;370(9589):741-750.